Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-05-01
2007-05-01
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S069100, C435S320100, C536S023100, C424S093210
Reexamination Certificate
active
10728131
ABSTRACT:
Synthetic DNA molecules encoding papillomavirus proteins are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against papillomavirus infection through stimulation of neutralizing antibody and cell-mediated immunity.
REFERENCES:
patent: 5679509 (1997-10-01), Wheeler et al.
patent: 5820870 (1998-10-01), Joyce et al.
patent: 6019978 (2000-02-01), Ertl et al.
patent: 6123948 (2000-09-01), Whittle et al.
patent: 6159729 (2000-12-01), Hofmann et al.
patent: 7001995 (2006-02-01), Neeper et al.
patent: WO 96 00583 (1996-01-01), None
patent: WO 96 39178 (1996-12-01), None
Zhou Jian, et al.—Journal of Virology, vol. 73, No. 6, pp. 4972-4982, 1999.
Afghan, R. K., et al.—Immunology, vol. 95, No. Suppl. 1, p. 106, 1998.
Kotecha, M. T., et al.—Immunology, vol. 95, No. Suppl. 1P. 107, 1998.
Xu, Jianqing, et al.—Zhonghua Weishengwuxue He Mainyixue Zazhi, vol. 19, No. 3, 1999.
Smahel Michal, et al.—Oncology Reports, vol. 6, No. 1, pp. 211-215, 1999.
Nimako Mercy, et al.—Cancer Research, vol. 57, No. 21, pp. 4855-4861, 1997.
Borysiewicz, L. K., et al.—Lancet, vol. 347, No. 9014, pp. 1523-1527, 1996.
Toes Rene, E. M., et al.—Proceedings of the National Academy of Sciences of the United States, vol. 94, No. 26, pp. 14660-14665, 1997.
Hi Z, et al.—Virology, vol. 270, No. 1, pp. 146-161, 2000.
Chen Chien-Hung, et al.—Vaccine, vol. 18, No. 19, pp. 2015-2022, 2000.
Donnelly, et al.—Protection Aganist Papillomavirus . . . , pp. 314-320, 1996.
Bodey, et al.—Failure of Cancer Vaccines, pp. 2665-2676, 2000.
McCluskie, et al.—Route and Method of Delivery of DNA, 1999.
Orkin, et al.—Report and Reommendations of the Panel, pp. 1-41, 1995.
Rudinger—Characteristics of the Amino Acids, pp. 1-8, 1976.
Bowie, et al.—Deciphering the Message in Protein Sequences, Vo.. 247, 1990.
Chemical Compound (Encyclopaedia Britannica Online), 2001.
Moingeon, et al.—Challenges and Issues in New Vaccine, pp. 173-175, vol. 23, No. 4, 2002.
Bubenik, J. Int. J. Onocol., 2002;20:207.
Nakano et al.- J. Virol, vol. 71; pp. 101-109, 1997.
vol. No. 5, 1998 Biochemistry and Molecular Biology International, pp. 1005-1009.
Chen Ling
Jansen Kathrin U.
McClements William L.
Neeper Michael P
Schultz Loren D.
Finnegan Alysia A.
Giesser Joanne M.
Li Q. Janice
Merck & Co. , Inc.
LandOfFree
Synthetic human papilloma virus genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic human papilloma virus genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic human papilloma virus genes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760035